Management ChangeMay 15, 2026, 07:02 AM
Ocular Therapeutix Grants Inducement Awards to New SVP, Head of HR
AI Summary
Ocular Therapeutix, Inc. announced the appointment of Ms. Amy Ricca as its new SVP, Head of HR, effective May 11, 2026. As an inducement for her employment, the company granted Ms. Ricca a non-statutory stock option award to purchase up to 75,000 shares of common stock and restricted stock unit awards for 25,000 shares. The stock option has an exercise price of $9.28 per share and vests over four years, while the RSUs vest over three years.
Key Highlights
- Ocular Therapeutix appointed Ms. Amy Ricca as SVP, Head of HR, effective May 11, 2026.
- Granted a non-statutory stock option award to purchase up to 75,000 shares of common stock.
- Granted restricted stock unit awards representing the right to receive an aggregate of 25,000 shares of common stock.
- Stock option award has an exercise price of $9.28 per share.
- Stock option award vests over four years, with 25% on the one-year anniversary and monthly thereafter.
- Restricted stock unit awards vest over three years in equal annual installments.
Price Impact
More from OCUL